Global Cervical Total Disc Replacement Device Market, By Material (Metal-on-metal and Metal-on-biocompatible), By Design (Constrained, Semi-constrained, and Unconstrained), By End User (Hospitals, Ambulatory Surgical Center and Specialty Clinics, and Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 2.4 Billion in 2023, exhibiting a CAGR of 21.8% during the forecast period (2023-2030), as highlighted in a new report published by Coherent Market Insights.
Increasing adoption of inorganic strategies such as acquisition by the market players is expected to drive the global cervical total disc replacement device market growth over the forecast period. For instance, in April 2022, NuVasive, Inc., a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced the acquisition of Cervitech(R) Inc., a company focused on clinical approval of the PCM(R) cervical disc system, a motion preserving total disc replacement device. This acquisition allows NuVasive to accelerate its entry into the growing mechanical cervical disc replacement market.
Global Cervical Total Disc Replacement Device Market – Impact of Coronavirus (COVID-19) Pandemic
The COVID-19 pandemic and consequent lockdowns in various countries across the globe impacted the financial status of businesses across all sectors, including the private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry, mainly due to strict lockdowns in several regions. Private healthcare is one such sector that has been significantly impacted by the COVID-19 pandemic.
Moreover, the COVID-19 pandemic has had a significant impact on the global healthcare industry as a whole. Many medical device markets, including the orthopedic and spine sectors, experienced disruptions due to the pandemic. The focus of healthcare systems shifted towards managing and treating COVID-19 patients, leading to delays in elective surgeries and non-essential procedures.
During the pandemic, hospitals and healthcare facilities faced challenges such as reduced patient visits, limited access to healthcare services, and supply chain disruptions. These factors could have potentially affected the demand and adoption of cervical total disc replacement devices.
Global Cervical Total Disc Replacement Device Market- Key Developments
In 2020, Medtronic, one of the global medical device companies, released the two-year results of its Prestige LP Clinical Trial, a pivotal clinical trial conducted to compare treatment data of the investigational implant device, PRESTIGE LP Cervical Disc. The trial demonstrated that cervical total disc replacement with Prestige LP Disc showed statistically significant improvement in overall success rates and superior clinical outcomes compared to anterior cervical discectomy and fusion (ACDF).
In 2020, Orthofix, one of the leading medical device companies and a provider of spinal, orthopedic, bone growth, and motion preservation products, obtained regulatory approval from the Japanese Ministry of Health, Labour, and Welfare (MHLW) for its M6-C Artificial Cervical Disc., a product designed to mimic your spine's natural disc's structure and movement.
In 2019, Simplify Medical, a medical device company focused on cervical spinal disc arthroplasty, received the U.S.FDA approval for its Simplify Disc, becoming the first cervical total disc replacement device to gain FDA clearance since 2007. This approval provided an additional option for patients seeking cervical disc replacement.
Browse 35 Market Data Tables and 31 Figures spread through 180 Pages and in-depth TOC on “Global Cervical Total Disc Replacement Device Market”- Forecast to 2030, Global Cervical Total Disc Replacement Device Market, By Material (Metal-on-metal and Metal-on-biocompatible), By Design (Constrained, Semi-constrained, and Unconstrained), By End User (Hospitals, Ambulatory Surgical Center and Specialty Clinics, and Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
To know the latest trends and insights prevalent in this market, click the link below:
The increasing prevalence of degenerative disc disease is expected to drive the global cervical total disc replacement device market growth over the forecast period. For instance, according to the data published by the National Center for Biotechnology Information, on April 15, 2023, regardless of symptomatology (or lack thereof) in the patient, cervical degenerative disc disease prevalence rises with age. According to published research, 25% of individuals under the age of 40 had signs of disk degeneration or constriction at one level. About 60% of patients in the same cohort who were older than 40 were found to have this evidence.
Key Takeaways of the Global Cervical Total Disc Replacement Device Market:
- Global cervical total disc replacement device market is expected to exhibit a CAGR of 21.8% during the forecast period, due to the increasing prevalence of spine degeneration diagnoses. For instance, in March 2022, the average annual prevalence of spine degeneration (mean standard deviation across years) was 27.3-1.7%. When compared to men, it was higher in women (34.7-1.9% against 18.1-1.8%). Overall, there were 4.5-0.6% of cases of stenosis, 0.11-0.12% of spine curvature, 0.017-0.014% of DISH, 0.17-0.20% of spondylitis, 12.2-0.9% of disc degeneration, 8.9-1.0% of osteoporosis, and 1.4-0.6% of other spine degeneration, which is further expected to drive the market growth.
- Among design, the constrained segment is estimated to hold a dominant position in the global cervical total disc replacement device market over the forecast period. In February 2021, NuVasive, one of the leaders in the advancement of spinal technology, acquired Simplify Medical, the maker of the Simplify Cervical Artificial Disc (Simplify Disc), which was developed to replace the cervical total disc (cTDR). This purchase has strengthened the company's cervical full disc offering.
- Among regions, North America is estimated to account for the largest market share in the global cervical total disc replacement device market over the forecast period. For instance, in September 2021, Dymicron, a medical device company based in Utah, U.S., announced that its Triadyme- C Artificial Cervical Disc won the 2021 Best New Spine Technology Award presented by Orthopedics This Week, a widely read publication in the orthopedics industry. Triadyme- C Artificial Cervical Disc is a motion-preserving cervical artificial disc made of polycrystalline diamond.
- Major players operating in the global cervical total disc replacement device market include Stryker Corporation, Medtronic plc., Zimmer Biomet Holdings, Inc., Globus Medical, Inc., FH Orthopedics, Orthofix Medical Inc., NuVasive Inc., Centinel Spine, Inc., ZimVie, inc., and other prominent players.
